Biocatalysis technology develops rapidly, and enthusiasm for biocatalyst research and development continues to rise.

Catalysts can usually be divided into two categories: non-biological catalysts and biological catalysts. Biocatalysts refer to cell lines, strains or enzymes extracted from them obtained by conventional breeding or modern bioengineering methods. Compared with non-biological catalysts, biocatalysts have the advantages of fast reaction rate, low price, specific catalytic effect, and can be used at normal temperatures and pressures. They are widely used in detergents, biomedicine, food processing, papermaking, feed processing and other fields. .

Biocatalysis technology refers to technology that uses cell lines, strains, or enzymes extracted from them as biocatalysts to carry out catalytic reactions. Compared with ordinary chemical catalysis technology, biocatalysis technology has the advantages of mild reaction conditions, green and environmental protection, and has been applied in many fields. With the rapid economic development and scientific research progress, the maturity of my country’s biocatalytic technology continues to improve, and local companies and related scientific research institutions already have a number of invention patents. In this context, biocatalysts are important catalysts used in biocatalytic technology, and the development of the industry has further accelerated.

According to the “2023-2028 China Biocatalyst Industry Market In-depth Research and Development Prospects Forecast Report released by the Industrial Research Center, biotechnology Catalysts have a wide range of uses, with the biomedicine field being the largest demand end. Biocatalysts can be used to synthesize pharmaceutical intermediates and medicines. Diabetic drugs, anti-cancer drugs, antibacterial drugs, etc. are their end products. With the support of national policies and the improvement of independent research and development capabilities of local enterprises, the development of my country’s biopharmaceutical industry has accelerated. In 2022, the size of my country’s biopharmaceutical market will reach 4.5 trillion yuan, setting a record high. Driven by downstream demand, my country’s biocatalyst market space continues to expand.

In recent years, biocatalysts have gradually become a hot research topic in the pharmaceutical field, attracting many pharmaceutical companies to set up research and development and production tracks. The main players in my country’s biocatalyst market include Bailong Chuangyuan, Propulo Pharmaceuticals, Baifuan Biotech, Pharmaron Chemicals, and Azure Biotech. ProPharma focuses on the R&D and production of high-efficiency biocatalysts and is a leading biocatalyst enterprise in my country.

Attracted by market prospects, global enthusiasm for biocatalyst research and development continues to rise. In April 2022, the team of Professor Nicholas J. Turner of the University of Manchester in the United Kingdom successfully developed a multifunctional biocatalyst called EneIRED. This product can be used for reductive amination and conjugate reduction, and is expected to have broad application prospects in the field of organic synthesis in the future. .

Industry analysts said that biocatalysts have good application prospects in the field of biomedicine. With the gradual release of market demand, the development of the industry has further accelerated. . There are many biocatalyst manufacturers in my country, and their market size has further expanded due to continuous breakthroughs in biocatalytic technology. In the future, with in-depth research and technological advancement, the prosperity of my country’s biocatalyst industry will further increase.